{"id":6383,"date":"2026-04-29T11:19:10","date_gmt":"2026-04-29T11:19:10","guid":{"rendered":"https:\/\/voxzogopatient-pprd-001.azurewebsites.net\/en-us\/?page_id=6383"},"modified":"2026-06-17T10:01:18","modified_gmt":"2026-06-17T10:01:18","slug":"understanding-safety","status":"publish","type":"page","link":"https:\/\/www.voxzogo.com\/en-us\/understanding-safety\/","title":{"rendered":"Understanding Safety"},"content":{"rendered":"
Below are the most common side effects<\/span> seen in over 10% of children (aged 5 to 15 years) on VOXZOGO<\/span> over 1 year in a clinical trial<\/span>.*<\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n *Includes adverse reactions occurring in over 10% of VOXZOGO patients and more frequently in the VOXZOGO arm with a risk difference of ≥5% (ie, difference of >2 subjects) between treatment arms.<\/small> Sophie, 9 months old, on VOXZOGO since 3 months old<\/p>\n\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t – Amanda, Sophie’s mom<\/p>\n\t\t\t\t <\/div>\n \t\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t<\/div>\n<\/div>\n <\/div>\n <\/div>\n<\/div>\n\n The safety of VOXZOGO in children under 5 years old was similar to that seen in children ages 5 years and older.<\/p>\n Over 1 year, the most common side effects seen in over 10% of children on VOXZOGO (under 5 years old) were injection site reactions (86%) and rash (28%).<\/p>\n *Data combined from children under 2 years old and 2 to under 5 years old at the start of treatment in clinical trials.<\/small> Learn about administering treatment to your child.<\/p>\n \n \n Your local BioMarin representative can help you find answers.<\/p>\n \n
<\/div>\n <\/figure>\n\nIn ongoing studies of VOXZOGO, the side effects observed for up to 6 years of treatment are similar to those seen in the first year.<\/h3>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
<\/div>\n \n
It’s important to know:<\/h3>\n \n
\n
\n
\n†<\/sup>Injection site reactions occurring more frequently in VOXZOGO-treated subjects than placebo.<\/small>
\n‡<\/sup>Includes the preferred terms: gastroenteritis and gastroenteritis, viral.<\/small><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n“We did our research, and knowing that VOXZOGO has been prescribed to over 5,000 children and is available from birth made us confident in our decision to treat Sophie with it.”<\/h2>\n
Children under 5 years old<\/h3>\n
In ongoing studies of VOXZOGO, the side effects observed for up to 4 years of treatment (see table below) are similar to those seen in the first year.<\/h3>\n <\/div>\n\n
<\/div>\n <\/figure>\n <\/div>\n <\/div>\n<\/div>\n\nIn children who started treatment at 4 months to under 2 years old,<\/strong>
\nthe side effects observed after 4 years of treatment were similar<\/strong>
\nto those seen in children who started treatment at age 2 years or older.<\/h2>\n \n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
\n†<\/sup>None of the hypersensitivity side effects were severe, medically significant, or life threatening.<\/small>
\n‡<\/sup>None of the injection site reaction side effects were moderate, severe, medically significant, or life threatening.<\/small><\/p>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\nGiving VOXZOGO<\/h3>\n \n
See How <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/div>\n\n
Looking for more information about VOXZOGO?<\/h2>\n <\/div>\n